CORONAVIRUS (COVID-19) and UBC’s response: please review the general information and FAQs and Postdoc-specific information.

Roadmaps to human biology-based disease research

Updated March 2018: The current application period for this opportunity is now closed. Please check back at a later time for infomation about the next competition.

To support strategic scientific dialogue around the concept of extending the vision of “21st century toxicology” to the wider biosciences, Humane Society International and The Humane Society of the United States are offering grants of up to $10,000 (USD) in funding to support the development and open-access publication of in-depth, independent review articles in discrete areas of human disease/biomedicine by health scientists with relevant expertise.

Each review should:

  • Examine the state of the science in a specific area of human biomedicine, including current understanding of the underlying pathophysiological pathways and networks;
  • Critically evaluate the human relevance, translational success and limitations of conventional research models;
  • Offer concrete recommendations/roadmap for optimizing the funding and use of advanced, human-specific tools and approaches (pathway paradigm as an organizing framework, primary human cells/tissues, iPSC, organoids, bioengineering, computational systems biology modeling, etc.) in the disease area under discussion; and
  • Be accepted for publication in a high-visibility, peer-reviewed journal.



Application Procedures

Please refer to the Human Toxicology Project Consortium website for application procedures.

Eligibility Requirements

Who can apply
  • Health researchers holding a PhD (or equivalent) degree and be able to demonstrate relevant experience in the disease area they propose to review.
  • Eligible individuals may currently be employed in a health research position in the academic, private or public sectors, or may have retired from such a position.
  • Applications will be accepted from single authors or groups.
  • The current call is restricted to applicants in the United States, Canada, European Union and South Korea.
How to Apply
  • The application form can be downloaded and submitted by email. Applicants must read the funding conditions below before completing their application.
  • A brief CV of no more than two pages for each applicant is also required, and PDFs of up to four recent publications in the field of the disease that they wish to review should be included.
  • High visibility publication of the review is a requirement of this funding; therefore, applicants are required to identify three candidate peer-reviewed journals of suitable remit for their proposal.

Final applications should be submitted by email to Dr. Lindsay Marshall at

Funding Conditions

It is expected that grant funding shall be used to enable applicants to dedicate their time to the production of a high-quality review article within a relatively short (3-4 month) timeframe, and will be used to cover the open-access article publishing charge for publication in an appropriate open-access peer-reviewed scientific journal.

Successful applicants shall be paid in arrears under the following terms and conditions:

  • $3,500 shall be payable upon completion of the review to the satisfaction of HSI/HSUS;
  • $6,500 shall be payable upon acceptance for publication by an appropriate, open-access peer-reviewed scientific journal agreed by HSI/HSUS;

Disease areas not eligible funding under this call include Alzheimer’s and Parkinson’s disease, addiction, ALS/motor neuron disease, stroke, asthma/COPD, autism, tuberculosis, liver cholestasis and autoimmunity, as extensive reviews are already available.

Annual Value

Up to $10,000 USD